enhance the development of colonic neoplasia induced by Alterations in folate status may play an important role in 1,2-dimethylhydrazine when compared with rats fed diets carcinogenesis. The aim of this study was to examine containing 8 mg/kg folic acid (11). In another study (12), the effect of a diminished folate status on azoxymethane folate deficiency increased the tumour incidence and number (AOM)-induced intestinal tumours in Sprague-Dawley of tumours in rats when compared with rats consuming an rats. A total of 125 weanling male rats were divided into adequate folate diet. In a further study, folate supplementation five equal groups and fed semi-purified diets containing at 2000 mg/kg was found to have increased the colon tumour either 8 mg/kg folate or no folate. After 4 weeks on size and multiplicity in rats that had been injected with the experimental diets, all animals received three weekly carcinogen azoxymethane (AOM) (13), while others (9) found subcutaneous injections of AOM at a dose rate of 15 mg/ that folate did not affect colon tumour incidence or tumour kg bodyweight. The animals were necropsied after 26 multiplicity. Other studies have also reported conflicting results weeks. Rats with a diminished folate status, evident by (14) (15) (16)(17). These conflicting results between these experimental significantly reduced blood and colonic folate concentraanimal observations may well be due to variations in experitions and elevated plasma homocysteine levels, had signimental design, diets or to differing animal models used by ficantly (P < 0.01) lower incidence and number of small researchers. intestinal and colonic tumours compared with rats disFolate is necessary for the biosynthesis of purines and playing an adequate folate status. There was a significant thymine, as well as the maintenance of S-adenosylmethionine decrease in the incidence of colonic adenocarcinomas (P < (SAM) levels for methylation reactions (18). An alteration in 0.01) and size of colonic tumours observed in the rats DNA methylation has been suggested to be an important displaying a diminished folate status. This study shows factor in causing genetic instability (19, 20) and is thought to that a diminished folate status was associated with a contribute to carcinogenesis by affecting the expression of decrease in the development of AOM-induced colorectal proto-oncogenes and/or tumour suppressor genes (21). DNA cancers. The decrease in risk may be attributed to the hypomethylation within the colon has been proposed as a known role of folate in cell multiplication.
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possible mechanism by which folate deficiency might enhance colorectal carcinogenesis (22). The purpose of this study was to determine whether a Introduction diminished folate status might alter the development of Colorectal cancer is one of the most common cancers occurring intestinal tumours induced by AOM in male Sprague-Dawley in men and women in the western world (1). Dietary factors rats. A secondary objective was to test if DNA methylation are thought to play a predominant role in the causation of was altered in the folate-depleted groups. Succinylsulfathiazole colorectal cancer. Diets high in fat and/or meat and low in fruits, (a non-absorbable antibiotic drug) was employed in some cereals and/or vegetables have been found to be associated with dietary treatments to further enhance the level of folate a higher risk of colorectal cancer (2, 3) . The reduced risk of depletion both before cancer initiation and during the promocolorectal cancer in association with consumption of fruits, tional/progression phase of carcinogenesis. cereals and vegetables may be explained by certain micronutrients (4). A higher intake of the micronutrient folate was Materials and methods first proposed by Freudenheim (5) ished folate intake and increased risk of developing colorectal At the age of 4 weeks they were sorted into equal bodyweights and divided into five dietary treatment groups of 25 animals. The animals were fed cancer (7). However, none of these studies relate actual folate experimental powdered diets ad libitum and given free access to distilled deficiency with increased colorectal cancer risk. Animal studies water for a period of 26 weeks. Body weights were recorded weekly. After 4 performed under controlled conditions have directly examined weeks on experimental diets, animals were injected subcutaneously with AOM (Sigma Chemical Co., St Louis, MO) dissolved in normal saline at a dose of 15 mg/kg body weight, given weekly for 3 weeks. The rats were killed 22 Abbreviations: AOM, azoxymethane; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine; SCFA, short chain fatty acids.
weeks after the first AOM injection. The experimental diets were based on modified AIN-93 (23) semi-purified diet (Table I) . Treatment 1 ('control') embedded in paraffin blocks, from which histological sections (4 mm) were cut and stained with haematoxylin and eosin. Tumours were identified as to type contained 8 mg folate/kg diet (folate adequate). Treatment 2 ('control ϩ S') was control with 1% succinylsulfathiazole added (Sigma Chemical Co.) for and graded with regard to malignancy and penetration according to Duke's classification (24) and classified as either adenoma or adenocarcinoma. The the first 4 weeks of the study. In treatment 3 ('FD') no added dietary folate was added. Rats in treatment group 4 ('FD1') consumed FD diet and 1% tumour incidence in a treatment group was defined as the percentage of rats in that group which contained at least one tumour. Tumour burden was the succinylsulfathiazole for the first 4 weeks of the study. Those in treatment group 5 (FD2) consumed FD and 1% succinylsulfathiazole for 4 weeks number of tumours per treatment group. The size and growth of the colon tumours (tumour mass index) was measured according to the following between weeks 8 and 12 of the study. The experimental protocol for the study is shown in Figure 1 .
formula:
The experimental protocol and use of rats was approved by the CSIRO, Health Sciences and Nutrition, Animal Experimentation and Ethics Committee where D 1 and D 2 are the diameters of the tumour. before commencing the study.
Approximately 3 cm of fresh colon tissue (distal colon) was scraped with Sample collection and autopsy a glass microscope slide. The mucosal cells collected were immediately frozen Fresh faecal samples were collected from each rat after 4 weeks on experimental in liquid nitrogen and stored at -80°C along with a piece of liver for diets. Faeces of a known weight were placed in 3 ml of deionized water and subsequent DNA extraction and DNA methylation analysis. A section of the homogenized; the pH was read and then the samples were stored at -20°C colon was also stored at -80°C for subsequent folate analysis. for SCFA measurements. The rats were killed by exsanguination while under Analytical methods halothane anaesthesia after 26 weeks on experimental diets. Blood was collected into EDTA-treated tubes. A portion of the blood was diluted with
Whole blood folate was determined by HPLC with fluorescence detection 1% ascorbic acid and stored at -80°C for subsequent folate analyses. The (25) . Total plasma homocysteine was measured by HPLC using the fluorimetric remaining blood was centrifuged at 1000 ϫ g for 10 min and plasma was method of Vester and Rasmussen (26) . Concentrations of SAM and collected and stored at -80°C for subsequent homocysteine measurements.
S-adenosylhomocysteine (SAH) in the liver and colon were determined by The colon and small intestine were immediately cut open longitudinally; the HPLC with UV detection (27). location, number and size of macrocopic tumours were recorded for each
The DNA from colonic mucosal scrapings and a small portion of the liver animal and the tumours were then removed and fixed in 10% formalin in was isolated using a High Pure PCR Template preparation kit (Boehringer phosphate-buffered saline for histopathological examination. Tumours were Mannheim) followed by treatment with 10 mg/ml RNase which had been preheated to 100°C for 15 min and cooled slowly to room temperature. The DNA was subsequently purified after precipitation with ethanol. Global colonic DNA methylation status at the CpG dinucleotides was assayed using a ionization detection. Gas chromatograph conditions were as follows: injector c The vitamin and mineral mixtures were prepared according to the AIN-76 temperature of 180°C, detector temperature of 220°C, column temperature of formula. The control diets contained 8 mg/kg folate, supplied through the 110°C and helium as the carrier gas at a flow rate of 30 ml/min. A standard vitamin mix.
SCFA mixture containing acetate, butyrate and propionate was used for d The 'control ϩ S' diet contained 1% succinylsulfathiazole only for the first calculation; the results are expressed as µmol/g faeces. 4 weeks of the study, FD1 also contained 1% succinylsulfathiazole only for Statistical analysis the first 4 weeks of the study; FD2 contained 1% succinylsulfathiazole only between weeks 8 and 12 of the study.
Group results of biochemical markers were compared using a one-way analysis of variance test followed by Tukey's multiple comparison test. Analysis of tumour incidence was carried out using chi-squared test, and a generalized linear model with Poisson distribution of errors was used to analyse differences between treatments for tumour numbers in the large and small intestines. For tumour mass index, the data were logarithmically transformed to allow for normality of data and then analysed using a one-way analysis of variance (ANOVA). The Kruskall-Wallis post hoc test was used after ANOVA to determine group differences. Differences between the treatment means for all tests were considered significant at P Ͻ 0.05 unless otherwise stated. Statistical analyses of tumour data were undertaken by CSIRO Mathematical and Information Services (Glen Osmond, South Australia).
Results
The rats in all dietary groups showed a similar weight gain; at the final week there was no significant difference among The incidence, number, type and size of intestinal tumours the treatment groups that consumed the folate-depleted diets. Haematocrit values did not differ between any of the treatment are shown in Table II . Most of the tumours observed in all treatment groups were in the large intestine. There was no groups (Table III) . Plasma homocysteine concentrations (Table  III) were significantly higher (P Ͻ 0.001) in the animals fed effect of the added succinylsulfathiazole treatments on tumour parameters, so treatment groups were pooled into folate-replete the folate-depleted diets. SAM concentrations in the liver (Table IV) were significantly decreased in the folate-deficient treatment or folate-depleted treatments. The control groups (folate-supplemented) demonstrated the highest number of treatments (P Ͻ 0.001). SAH concentrations in the liver were not significantly different. When expressed as a ratio tumour-bearing animals, 100% for control and 88% for control ϩ S, whereas the folate-depleted treatments showed the lowest (SAM:SAH) there was a significant decrease (P Ͻ 0.001) in the folate-deficient treatment groups. No significant differences number of tumour bearing animals, 76% for FD, 68% for FD1 and 70% for FD2. Overall there was a significant decrease were observed with SAM within the colonic mucosa for any of the treatment groups. SAH within the colonic mucosa could (P Ͻ 0.01) in total tumour (small intestinal ϩ colonic) incidence and number of tumours associated with the folatenot be measured by HPLC due to interfering peaks. The results of DNA methylation status in the colonic mucosa depleted treatments. Histopathological appraisal of colon tumour type showed that the animals fed the folate-depleted are shown in Table IV . There were no significant differences observed among the four groups in the level of unmethylated diets developed significantly fewer (P Ͻ 0.01) adenocarcinomas than the folate-supplemented treatment groups.
CpG within the colonic mucosa, despite the marked folate deficiency observed in the FD, FD1 and FD2 treatments. There was a 71% fall in the incidence of malignant tumours in the folate-depleted treatment groups (P Ͻ 0.01).
Total SCFA concentrations in the faeces and faecal pH were significantly decreased (P Ͻ 0.01) after 4 weeks as a result of Tumour mass index (log 10 ) data for large intestinal tumours also showed a significant reduction (P Ͻ 0.05) in the animals incorporation of succinylsulfathiazole at a level of 1% into the diet. SCFA concentrations (µmol/g) were as follows (mean Ϯ maintained on folate-depleted diets, when compared with those consuming adequate folate. Table III . Whole blood folate concentrations were Ϯ SD): control, 6.9 Ϯ 0.2; cont ϩ S, 6.4 Ϯ 0.1; FD, 6.9 Ϯ 0.3; FD1, 6.2 Ϯ 0.1. significantly reduced (P Ͻ 0.001) in the treatment groups that consumed the folate-depleted diets. Colonic mucosa folate concentrations also were significantly depleted (P Ͻ 0.01) in Discussion
The main aim of the present study was to examine the effect of folate deficiency on intestinal tumorigenesis in the rat. The study this inhibition of the intestinal microflora was evident n ϭ 25 rats/treatment. 'Control' and 'control ϩ S' are folate-replete after 4 weeks in the rats consuming succinylsulfathiazole, by treatments while FD, FD1 and FD2 are folate-deficient treatments. The significant decreases in faecal pH and in SCFA concentrations.
treatment groups were pooled to give 'folate replete' and 'folate deficient'.
SCFAs are produced when the intestinal microflora break a Significance of difference between folate-supplemented and folate-deficient. n.s., not significant.
down non-starch polysaccharides and resistant starch (31). In Table III . Haematological parameters, blood and colonic folate and plasma homocysteine values in folate-depleted and folate-replete rats
Haematocrit (%) 38.0 Ϯ 2.9 37.5 Ϯ 2.9 37.5 Ϯ 1.5 37.8 Ϯ 3.5 37.0 Ϯ 2.8 Leukocyte (WBCϫ10 6 /ml blood) 6.2 Ϯ 3. Values are mean Ϯ SD with 25 rats/group. Means with different superscript letters in each row are significantly different (P Ͻ 0.05).
theory, by inhibiting the intestinal microflora's production of period of induction and dosage used were substantially longer (20 weeks for dosing protocol) than that of three weekly AOM folate, a more extreme level of folate deficiency may be attained at a particular time. In a previous study (10) we injections used in the present study. It is a more artificial form of diet perturbation than was used in the present study. The demonstrated that the level of folate depletion can be enhanced in rats after feeding a folate-deficient diet supplemented with contrasting results (11, 12) to those of the present study are hard to explain but differences in experimental diet composition succinysulfathiazole for 4 weeks. However, the incorporation of succinylsulfathiazole into the treatments either before cancer may account for differences. The larger dose for initiation than that used in the present study may offer another explanation. initiation or after initiation did not further influence intestinal tumour outcomes in this study.
Concentrations of folate in the blood and the colonic mucosa were significantly depleted in the animals fed folate-deficient The reduced intestinal tumorigenesis as a result of folate deficiency in the present study was not entirely unexpected, diets. There was a modest rise in homocysteine only in the animals that exhibited decreased blood folate concentrations, as other experimental animal studies have also shown that folate deficiency can suppress or delay the onset of tumours adding further evidence of biochemically significant folate deficiency. The level of folate deficiency observed in rats in (14, 16, 17) . Folate plays an important role in nucleic acid biosynthesis and processes involved in cell proliferation (32) .
the present study can be regarded as moderate and is consistent with other studies (10, 11, 39) which demonstrated moderate An association of folate supplementation with enhanced cancer induction in humans has been suggested previously (33) and folate deficiency. It is not necessary to resort to a pure amino acid diet to achieve such deficiency. This magnitude of folate may be an effect of a requirement of tumour growth for folate. Indeed, interruption of folate metabolism is a basis for antidepletion has previously been shown to be associated with a significant degree of cellular folate depletion within the colonic tumour therapy (34). In the colon, enhancement of cell proliferation is considered a risk factor for tumour development mucosa (40) and this has again been observed in the present study. Further evidence of moderate folate deficiency was that (35) . Thus, a reduction in cell proliferation is a proposed mechanism for chemoprevention (36). It is plausible, therefore, body growth of the animals was not affected nor was there any alteration in haematocrit or white cell levels. that folate deficiency may well be reducing tumorigenesis by inhibiting cell proliferation. In the present study, folate
Alterations in global methylation patterns are among the earliest abnormalities to occur during the development of deficiency supports suppression of promotion/progression events in intestinal cancer, as both the incidence and number colorectal cancer (41), although whether this is biologically significant is uncertain. Folate plays a key role in the transfer of intestinal tumours were reduced. However, we were unable to determine whether folate is important before development of methyl units to donor compounds (32), including many biological transmethylation reactions such as that of DNA of intestinal tumours; a deficiency of folate in the later stages of tumourigenesis certainly reduces tumour development. In a (42). It has been proposed (11, 22 ) that altered DNA methylation as a result of changes in folate status may be a mechanism previous study (10) using ACF as a biomarker for colorectal cancer risk, we found no alteration in total ACF numbers in whereby colorectal tumourigenesis is enhanced. In the present study, folate supplementation or folate deficiency did not alter the colon between rats fed an adequate folate diet and those consuming a folate-deficient diet which results in moderate global DNA methylation in the colonic mucosa. Other studies have also demonstrated that genomic DNA methylation status folate deficiency, suggesting that folate does not offer protection in the early stages of tumorigenesis.
in the colonic mucosa is not altered by folate supplementation or folate deficiency (12, 43) . In the present study, colonic The American Institute of Nutrition (AIN) diet is widely used when investigating chemopreventive agents in rat carcinomucosal SAM concentrations did not change as a result of folate deficiency. SAM is the proximal methyl donor for DNA genesis studies (37,38). In the present study the background diet consisted of a semi-purified AIN-93 rodent diet that was methylation reactions (42). The colon may well be resistant to changes in SAM concentrations and DNA methylation (43). modified to contain 12% protein supplied as casein and 20% fat supplied as a lard-sunflower oil mix. In these studies,
The results of the present study demonstrate that folate deficiency reduces the development of tumorigenesis right folate was fed at a level of 8 mg/kg in the folate-supplemented diets and there was no added folic acid in the folate-deficient through to cancer in AOM-treated rats. This was emphasized by a reduction in intestinal tumour incidence and the smaller diets. Other studies (11, 12) used a specific high glutamate amino acid defined diet in showing an increased risk of number of intestinal tumours observed in the folate-deficient animals. While the incidence and tumour number were not colorectal cancer with folate deficiency. Folate was also at 8 mg/kg in the adequate folate diet. There was no added folic significantly reduced by folate deficiency in the large intestine, there were fewer malignant tumours and a reduction in the acid in the folate-deficient diet. Dimethylhydrazine was used as the carcinogen to induce colorectal carcinogenesis and the tumour mass index. Folate deficiency did not alter the global
